Cannabis News Australia | Cannabiz

Arovella Therapeutics0.05-0.001Avecho Biotechnology0.014Botanix Pharmaceuticals0.0120Cann Group0.0050.001ECS Botanics0.005Elixinol Wellness0.007Emyria0.039-0.001Epsilon Healthcare0.022EVE Health Group0.0140IDT Australia0.03800Little Green Pharma0.065000Neurotech International0.0180.001Nexalis Therapeutics0.00900Vitura Health0.017-0.002Wellnex Life0.069-0.001Zelira Therapeutics0.50

Montu and TGA head to court as advertising case reaches climax

by Steve Jones

PGRs on regulator radar but industry consultation unlikely ahead of changes to TGO 93 standards

by Steve Jones

Helius oil to be tested in NZ sleep trial

by Adam Sheldon

ECS Botanics reports fifth quarter of positive operating cash flow

by Steve Jones

CANNABIZ PREMIUM

‘Not for the faint hearted’: Crisci Group facility gets green light to manufacture medicinal cannabis

Montu staff braced for fresh job cuts as costs remain ‘unsustainably high’

BLS Pharmaceuticals reports revenue spike in first quarter

Cannabis executive salaries: who earned what in FY26

RECENT NEWS

Aurora Cannabis explores new deals after rejecting revised Curaleaf offer

October 16, 2026October 16, 2026

‘We need to know where we want to go’: NZ industry to map out future as business leaders gather

October 14, 2026October 15, 2026

Council holds first TGO 93 meeting in bid to secure ‘uplift’ in standards

October 14, 2026October 14, 2026

News in brief: Grower raises $1.2m; Medigrowth gets endo stamp

October 10, 2026October 15, 2026

Number of SAS-B prescribers in September falls to lowest of the year

October 5, 2026October 5, 2026

TAFE cultivation course to unearth ‘next generation’ of local growers

September 30, 2026September 30, 2026

A mother’s memoir: New book lays bare the anguish, hope and campaigning battle of Lucy Haslam

September 29, 2026September 29, 2026

Rua launches NZ$2.8m capital raise in bid to continue revenue growth

September 25, 2026September 25, 2026